GlaxoSmithKline: all 4,196 studies
Page 26 of 42. Open to participants first (141), then studies with results posted, then the rest; newest registration first within each.
- This Will be an Open-label, Three-period, Fixed-sequence Study to Evaluate the Drug-drug Interaction, Pharmacokinetics and Safety of Dutasteride and Tamsulosin When Administered Alone and In-combination in Chinese Healthy Male Volunteers. The Study Will Last Approximately Eleven Weeks. Blood SamplesCompletedNCT01957189Phase 1
- Bioequivalence of RYTHMOL SR® Manufactured at Two Different SitesCompletedNCT01956487Phase 1
- A Pharmacokinetics (PK) Study of the Effects Rabeprazole and Rifampin on Dabrafenib in Subjects With BRAF V600 Mutation Positive TumorsCompletedNCT01954043Phase 1
- A Two-part Study to Investigate the Interaction and Pharmacokinetics of GSK2586184CompletedNCT01953835Phase 1
- Study Assessing Risk of Autoimmune Diseases in Females (9 - 25 Years) Exposed to Cervarix® in United KingdomCompletedNCT01953822
- A Pharmacokinetics, Pharmacodynamics, and Safety Study of an Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol When Co-administered With GSK1322322 in Healthy Adult WomenWithdrawnNCT01953809Phase 1
- Bioequivalence Study of Montelukast 10 mg TabletsCompletedNCT01943942Phase 1
- REMS Retigabine StudyCompletedNCT01938560
- Minocycline Bioequivalence StudyCompletedNCT01938508Phase 1
- Study to Evaluate the Safety, Tolerability and Pharmacokinetic of Single and 14 Day Repeat Topical Application of GSK1940029CompletedNCT01938482Phase 1
- Safety and Tolerability of Trametinib in Combination With Docetaxel in Japanese Subjects With Non-small Cell Lung CancerWithdrawnNCT01938456Phase 1
- A Dose Escalation Study to Assess Safety of GSK2256098 (FAK Inhibitor) in Combination With Trametinib (MEK Inhibitor) in Subjects With Advanced Solid TumorsCompletedNCT01938443Phase 1
- To Evaluate Plasma and Pulmonary Pharmacokinetics of GSK2140944CompletedNCT01934205Phase 1
- Characterization of Exposure From Topical Administration of [14C] Umeclidinium to Axilla or Palm of Healthy Male SubjectsCompletedNCT01934153Phase 1
- Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 21 to 64 Years of AgeCompletedNCT01934127Phase 1
- Phase 1 Dose Escalating Study to Assess Safety, Tolerability, Food Effect and PK of CHR-5154 in Healthy Male VolunteersTerminatedNCT01934101Phase 1
- Bioequivalence Study of Dutasteride Five 0.1 mg and One 0.5 mg Soft Gelatin Capsules in Healthy Male VolunteersCompletedNCT01929330Phase 1
- W0265-103: A Single-Center, Evaluator-Blinded, Randomized, Placebo Controlled, Phase 1 Clinical Trial Evaluating The Phototoxic Potential Of Topically Applied Clindamycin 1.0% - Tretinoin 0.025% Gel (Ct Gel) In Healthy VolunteersCompletedNCT01929278Phase 1
- Tafenoquine Thorough QTc Study in Healthy SubjectsCompletedNCT01928914Phase 1
- A Positron Emission Tomography (PET) Study to Investigate the Brain Biodistribution of 18F GSK2647544 in Healthy Subjects to Determine Its Ability to Cross the Blood-brain-barrier.TerminatedNCT01924858Phase 1
- Place of Flixovate® in the Treatment Pathway and Its Conditions of Use in Infants Aged From 3 to 12 Months Between 2010 and 2012 by French GPs and Private PaediatriciansCompletedNCT01920464
- Study to Determine the Effect of 14 Days Dosing With Darapladib (SB-480848) on Carotid Plague Composition in Patients With Planned Carotid EndarterectomyCompletedNCT01916720Phase 2
- Efficacy and Safety of Paroxetine Controlled Release for Major Depressive Disorder in Irritable Bowel Syndrome PatientsWithdrawnNCT01916200Phase 4
- Study to Analyze the Clinical and Cost Impact of Complete and Incomplete Rotarix VaccinationCompletedNCT01915888
- W0265-104: A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Photoallergic Potential of Topically Applied Clindamycin Phosphate 1.0% and Tretinoin 0.025% (CT Gel) in Healthy VolunteersCompletedNCT01915758Phase 1
- Effectiveness of Belimumab Treatment in a Subpopulation of Systemic Lupus Erythematosus (SLE) Patients: a Pooled Analysis of BLISS-52 and BLISS-76CompletedNCT01914770
- Characterisation of T-cell Response to Keyhole Limpet Hemocyanin (KLH) and Tuberculin Purified Protein Derivative (PPD)CompletedNCT01910662Phase 1
- Post-marketing Safety Study to Assess the Risk of Spontaneous Abortions in Women Exposed to Cervarix Residing in UKCompletedNCT01905462
- Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) VaccinesCompletedNCT01905215Phase 1
- A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability, Immunogenicity, and Pharmacodynamics (PD) of GSK2800528 in Healthy Subjects.CompletedNCT01899755Phase 1
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of PruritusCompletedNCT01899703Phase 2
- Pharmacokinetics Of Umeclidinium and Vilanterol in Healthy Chinese, a Randomized, Open Label, 3 Crossover Study.CompletedNCT01899638Phase 1
- Pharmacokinetic Study in Healthy Volunteers to Characterise the Exposure of Fluticasone Furoate (FF), Vilanterol (VI) and Umeclidinium (UMEC) at Two Different DosesCompletedNCT01894386Phase 1
- A Study to Estimate the Relative Bioavailability, Tolerability and Safety of a Single Dose of Belimumab Self-Administered Subcutaneously (SC) by Healthy SubjectsCompletedNCT01894360Phase 1
- ROTAHALER Device Optimization StudyCompletedNCT01890863Phase 1
- Study to Analyze the Risk Factors Associated With Pertussis/Whooping Cough Infection Among InfantsCompletedNCT01890850
- Drisapersen Duchenne Muscular Dystrophy (DMD) Treatment ProtocolWithdrawnNCT01890798Phase 3
- Assessing Contacts' Decision Making on Reducing the Risk of Pertussis Transmission to Newborns Through ImmunisationCompletedNCT01890447
- Feasibility Study for Identifying Anti Capsular Antibody Protection Against Invasive Group B Streptococcus (GBS) Disease in Newborns of 0-6 Days Age (Early Onset Disease [EOD]) as Well as Among Infants of 7-90 Days Age (Late Onset Disease [LOD])CompletedNCT01888471Not applicable
- A First Time in Human Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single & Repeat Escalating Doses of GSK2878175 in Healthy SubjectsCompletedNCT01879462Phase 1
- The Bioequivalence Study of Lamotrigine Dispersible/Chewable Tablets 5mg×5 Compared With Lamotrigine Compressed Tablet 25mg in Chinese Healthy Male SubjectsCompletedNCT01879423Phase 1
- A Study to Assess the Burden of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults Aged Sixty Years and AboveCompletedNCT01873365
- Pharmacokinetic Interaction of Darapladib and CYP 3A4 in Healthy SubjectsCompletedNCT01873339Phase 1
- A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Retosiban (GSK221149) When Dosed With Efavirenz (EFZ)CompletedNCT01867996Phase 1
- Bioequivalence Study of Montelukast 5 mg ChewableCompletedNCT01863654Phase 1
- Bioequivalence Study for an IsotretinoinCompletedNCT01863615Phase 1
- Special Drug Use Investigation for LAMICTAL® (Long Term)CompletedNCT01863602
- Drug Use Investigation for HEPSERA (Adefovir) TabletCompletedNCT01863589
- Single Oral Dose Study of Atovaquone/Proguanil Hydrochloride Combination Tablets and Atovaquone SuspensionCompletedNCT01858831Phase 1
- A Pooled Analysis of the HGS1006-C1056 (BLISS-52) and HGS1006-C1057 (BLISS-76) StudiesCompletedNCT01858792
- Feasibility Study of Exenatide by Continuous Subcutaneous InfusionCompletedNCT01857895Phase 1
- Safety and Efficacy Study of GR68755 (Alosetron Hydrochloride) to Treat Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS)CompletedNCT01855711Phase 2
- Bioequivalence Trial of Alprazolam 0.25 mg TabletsCompletedNCT01853956Phase 1
- Study to Determine the Effect of Repeated Administration of Diltiazem on the Pharmacokinetics of Darapladib (Sb-480848).CompletedNCT01852565Phase 1
- An Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult SubjectsCompletedNCT01848340Phase 1
- Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of Acetylsalicylic Acid (ASA) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fed ConditionsCompletedNCT01847417Phase 1
- Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of ASA (Acetylsalicylic Acid) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fasting ConditionsCompletedNCT01847404Phase 1
- Analysis of the Incidence of Expression of Tumor Antigens in Pathologically Proven Stage I, II and III Non-Small Cell Lung Cancer(NSCLC) in Asiatic PatientsCompletedNCT01837511
- A Study to Assess the Bronchodilator Effect of a Single Dose of Fluticasone Furoate (FF)/ Vilanterol (VI) 100/25 Micrograms (mcg) Combination When Administered in Adult Patients With AsthmaCompletedNCT01837316Phase 1
- Study to Evaluate the Pharmacokinetics and Safety of GSK2336805 in Subjects With Hepatic Impairment and Healthy Matched Control SubjectsCompletedNCT01827657Phase 1
- Bioavailability and Food Effect of the Original Gelatin Formulation and Two New Formulations of Afuresertib in Normal Healthy VolunteersCompletedNCT01827644Phase 1
- Single and Repeat Dose Pharmacokinetic Study of GSK1605786 in Healthy Chinese SubjectsCompletedNCT01827631Phase 1
- A Fixed Dose Combination Amlodipine + Enalapril Bioavailability StudyCompletedNCT01822639Phase 1
- A Study to Investigate the Safety Tolerability Pharmacokinetics, and Pharmacodynamics of Inhaled and Intravenous GSK2862277 in Healthy VolunteersCompletedNCT01818024Phase 1
- A Three-part Study to Determine the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Volunteers and Healthy Male Japanese SubjectsTerminatedNCT01818011Phase 1
- Retapamulin Microdialysis Feasibility StudyCompletedNCT01812382Phase 1
- A First Time in Human Study Exploring Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2618960 in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis (RRMS)TerminatedNCT01808482Phase 1
- N. Meningitidis Carriage StudyCompletedNCT01808365
- Post-marketing Safety Study of GlaxoSmithKline (GSK) Biologicals' Synflorix™ Vaccine, in Healthy Infants and Children in Sri LankaWithdrawnNCT01803425
- A Study to Evaluate the Effect of GSK1322322 on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy VolunteersWithdrawnNCT01803399Phase 1
- GSK239512 DDI StudyCompletedNCT01802931Phase 1
- Single Dose Escalation Study of GSK2838232 in Healthy SubjectsCompletedNCT01802918Phase 1
- Study in Healthy Volunteers, to Evaluate the Safety, Efficacy and Dose Responses of SB-751689 (Ronacaleret)CompletedNCT01802892Phase 1
- Study to Determine the Bioequivalence of Two Fixed Dose Combination (FDC) Tablet Formulations of Amlodipine and Losartan FDC5/50 and FDC5/100 Under Fasting ConditionsCompletedNCT01797926Phase 1
- A Study in Healthy Volunteers to Evaluate the Application of Stable Isotope Approach to Reduce Number of Subjects Needed for PK StudiesCompletedNCT01793870Phase 1
- Healthcare Seeking Behaviour of Primary Caregivers for Acute Otitis Media (AOM) in Children Aged 6 Months to Less Than 30 Months in PanamaCompletedNCT01793857
- To Investigate the Safety, Pharmacodynamics and Effect on Allergic Reactivity of the Toll-like Receptor 7 (TLR7) Agonist GSK2245035 in Subjects With Respiratory AllergiesCompletedNCT01788813Phase 2
- Acceptability of Hepatitis B Vaccination in General PopulationCompletedNCT01782794
- Treatment Options in Human Epidermal Growth Factor Receptor 2 (HER2) Positive Metastatic Breast Cancer PatientsCompletedNCT01782651
- An Adaptive Phase II Study to Evaluate the Efficacy, Pharmacodynamics, Safety and Tolerability of GSK2586184TerminatedNCT01777256Phase 2
- A Study to Evaluate the Safety of GSK2398852 When Co-administered With GSK2315698 in Patients With Systemic AmyloidosisCompletedNCT01777243Phase 1
- Acceptability of Hepatitis B Vaccination in General Practitioners and PaediatriciansCompletedNCT01777074
- An Expanded Access Protocol for Subjects Who Have Completed Clinical Studies Involving MaravirocNo longer availableNCT01776996
- Bioequivalence Study of an Amoxicillin-ClavulanicCompletedNCT01772238Phase 1
- NSCLC Burden of Illness StudyCompletedNCT01772225
- Bioequivalence Study for Terbinafine 250 mgCompletedNCT01772212Phase 1
- Study to Assess Whether GSK239512 Can Remyelinate Lesions in Subjects With Relapsing Remitting Multiple SclerosisCompletedNCT01772199Phase 2
- Bioequivalence Study of Cephalexin Tablets 1gCompletedNCT01767584Phase 1
- Bioequivalence Study of Cephalexin Suspension 250CompletedNCT01767571Phase 1
- Bioequivalence Study of Cephalexin Suspension 125CompletedNCT01767532Phase 1
- Study of Dabrafenib +/- Trametinib in Combination With Ipilimumab for V600E/K Mutation Positive Metastatic or Unresectable MelanomaCompletedNCT01767454Phase 1
- Pharmacokinetic Study to Compare Two Formulations of ParacetamolCompletedNCT01767428Phase 1
- Study to Evaluate Safety, Reactogenicity and Immunogenicity of the Pneumococcal Protein PhtD Vaccine in Healthy AdultsCompletedNCT01767402Phase 1
- Glucagon-like Peptide (GLP) Utilization and SafetyCompletedNCT01767389
- WEUSKOP5723: Prostate Cancer StudyCompletedNCT01767363
- WEUSKOP6416: Evaluating Pneumonia in Chronic Obstructive Pulmonary Disease (COPD) SubjectsCompletedNCT01763463
- A Study to Evaluate the Effects of Calcium Carbonate and Ferrous Fumarate on Pharmacokinetics of Dolutegravir in Healthy Adult SubjectsCompletedNCT01762995Phase 1
- A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of the Dry Powder Formulation of GSK2269557 in Healthy SubjectsCompletedNCT01762878Phase 1
- Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous NephropathyWithdrawnNCT01762852Phase 2
- Phase I Methodology Study to Validate the Cantharidin Blister Model in Healthy VolunteersCompletedNCT01762787Phase 1